Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy (original) (raw)
Gulick, R.M. et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med.337, 734– 739 (1997). ArticleCAS Google Scholar
Hammer, S.M. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med.337, 725– 733 (1997). ArticleCAS Google Scholar
Palella, F.J. Jr. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med.338, 853– 860 (1998). Article Google Scholar
Chun, T.W. et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA94, 13193–13197 (1997). ArticleCAS Google Scholar
Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science278, 1295–1300 (1997). ArticleCAS Google Scholar
Wong, J.K. et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science278, 1291– 1295 (1997). ArticleCAS Google Scholar
de Jong, M.D. et al. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS11, F79– 84 (1997). Article Google Scholar
Cohen, O.J. & Fauci, A.S. HIV/AIDS in 1998-gaining the upper hand? J. Am. Med. Assoc.280, 87– 88 (1998). ArticleCAS Google Scholar
Cohen, J. Exploring how to get at—and eradicate—hidden HIV. Science279, 1854–1855 ( 1998). ArticleCAS Google Scholar
Ho, D.D. Toward HIV eradication or remission: the tasks ahead. Science280, 1866–1867 (1998). ArticleCAS Google Scholar
Chun, T.W., Engel, D., Mizell, S.B., Ehler, L.A. & Fauci, A.S. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J. Exp. Med.188, 83–91 (1998). ArticleCAS Google Scholar
Schrager, L.K. & D'Souza, M.P. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. J. Am. Med. Assoc.280, 67–71 (1998). ArticleCAS Google Scholar
Kovacs, J.A. et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin- 2 in patients with human immunodeficiency virus infection. A preliminary study. N. Engl. J. Med.332, 567–575 (1995). ArticleCAS Google Scholar
Kovacs, J.A. et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N. Engl. J. Med.335, 1350–1356 (1996). ArticleCAS Google Scholar
Jacobson, E.L., Pilaro, F. & Smith, K.A. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc. Natl. Acad. Sci. USA93, 10405–10410 (1996). ArticleCAS Google Scholar
Davey, R.T. Jr. et al. Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons. J. Infect. Dis.175, 781–789 (1997). ArticleCAS Google Scholar
Carr, A. et al. Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group. J. Infect. Dis.178, 992– 999 (1998). ArticleCAS Google Scholar
Kelleher, A.D. et al. Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens. Clin. Exp. Immunol.113, 85– 91 (1998). ArticleCAS Google Scholar
Simonelli, C. et al. Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia. AIDS12, 112–113 (1998). CASPubMed Google Scholar
Witzke, O. et al. Comparison between subcutaneous and intravenous interleukin-2 treatment in HIV disease. J. Intern. Med.244, 235–240 (1998). ArticleCAS Google Scholar
Pawelec, G. et al. Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status. Biotherapy3, 309–318 (1991). ArticleCAS Google Scholar
McIntyre, C.A. et al. Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants. Eur. J. Cancer.28, 58– 63 (1992). ArticleCAS Google Scholar
Weidmann, E., Bergmann, L., Stock, J., Kirsten, R. & Mitrou, P.S. Rapid cytokine release in cancer patients treated with interleukin-2. J. Immunother.12, 123 –131 (1992). ArticleCAS Google Scholar
Chun, T.W. et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA95, 8869–8873 ( 1998). ArticleCAS Google Scholar
Chun, T.W. et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature387, 183–188 (1997). ArticleCAS Google Scholar
Zhang, L. et.al. Quantifying residual HIV-1 replication and decay of the latent reservoir in patients on seemingly effective combination antiretroviral therapy. N. Engl. J. Med. (in the press).
Bich-Thuy, L.T. et al. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. J. Immunol.139, 1550–1556 ( 1987). CASPubMed Google Scholar
Unutmaz, D., Pileri, P. & Abrignani, S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med.180 , 1159–1164 (1994). ArticleCAS Google Scholar
Natarajan, V. et al. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Lancet353, 119– 120 (1999). ArticleCAS Google Scholar
Cavert, W. & Haase, A.T. A national tissue bank to track HIV eradication and immune reconstruction. Science280, 1865–1866 (1998). ArticleCAS Google Scholar